Elpiscience (Suzhou) Biopharma

Elpiscience (Suzhou) Biopharma, based in Suzhou, China, is a biotechnology company. Elpiscience is a biopharmaceutical company developing immunotherapies for oncology and autoimmune disease. On ClinicalTrials.gov it is the lead sponsor of 2 recruiting or active phase 2 and phase 3 interventional cancer trials, testing ES014 and ES102 in desmoid tumour and non-small-cell lung cancer. The largest, NCT07541430 (A Study in Adults With Desmoid Tumours), plans to enrol 50 participants. Sponsor and trial facts are from the ClinicalTrials.gov registry; company facts are from the official website.